Saitama, Japan

Mariko Nagasawa

This inventor holds 1 USPTO granted patent. Top assignee: Yoshitomi Pharmaceutical Industries, Ltd.. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mariko Nagasawa. Retrieved from https://idiyas.com/inventor/mariko-nagasawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mariko Nagasawa: Innovator in Immunosuppressive Drug Development

Introduction

Mariko Nagasawa is a prominent inventor based in Saitama, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of immunosuppressive drugs. Her innovative work has the potential to impact the lives of many patients requiring such treatments.

Latest Patents

Mariko holds a patent for an immunosuppressive drug, showcasing her expertise and dedication to advancing medical science. This patent represents her commitment to finding solutions that can improve patient outcomes.

Career Highlights

Mariko is currently employed at Yoshitomi Pharmaceutical Industries, Ltd., where she continues to work on groundbreaking research and development projects. Her role at the company allows her to collaborate with other talented professionals in the pharmaceutical industry.

Collaborations

Mariko has worked alongside notable colleagues, including Takeki Okumoto and Kenji Chiba. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Mariko Nagasawa is a trailblazer in the field of immunosuppressive drug development. Her contributions to the pharmaceutical industry are invaluable, and her work continues to inspire future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…